Cargando…

Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats

BACKGROUND: Stem cells provide a promising candidate for the treatment of the fatal pediatric dilated cardiomyopathy (DCM). This study aimed to investigate the effects of intramuscular injection of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) on the cardiac function of a DCM rat mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Chenggang, Hou, Xu, Wang, Benzhen, Chi, Jingwei, Jiang, Yanjie, Zhang, Caining, Li, Zipu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273808/
https://www.ncbi.nlm.nih.gov/pubmed/28129792
http://dx.doi.org/10.1186/s13287-017-0472-y
_version_ 1782501785931350016
author Mao, Chenggang
Hou, Xu
Wang, Benzhen
Chi, Jingwei
Jiang, Yanjie
Zhang, Caining
Li, Zipu
author_facet Mao, Chenggang
Hou, Xu
Wang, Benzhen
Chi, Jingwei
Jiang, Yanjie
Zhang, Caining
Li, Zipu
author_sort Mao, Chenggang
collection PubMed
description BACKGROUND: Stem cells provide a promising candidate for the treatment of the fatal pediatric dilated cardiomyopathy (DCM). This study aimed to investigate the effects of intramuscular injection of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) on the cardiac function of a DCM rat model. METHODS: A DCM model was established by intraperitoneal injections of doxorubicin in Sprague-Dawley rats. hUCMSCs at different concentrations or cultured medium were injected via limb skeletal muscles, with blank medium injected as the control. The rats were monitored for 4 weeks, meanwhile BNP, cTNI, VEGF, HGF, GM-CSF, and LIF in the peripheral blood were examined by ELISA, and cardiac function was monitored by echocardiography (Echo-CG). Finally, the expression of IGF-1, HGF, and VEGF in the myocardium was examined by histoimmunochemistry and real-time PCR, and the ultrastructure of the myocardium was examined by electron microscopy. RESULTS: Injection of hUCMSCs markedly improved cardiac function in the DCM rats by significantly elevating left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS). The BNP and cTNI levels in the peripheral blood were reduced by hUCMSCs, while HGF, LIF, GM-CSF, and VEGF were increased by hUCMSCs. Expression of IGF-1, HGF, and VEGF in the myocardium from the DCM rats was significantly increased by hUCMSC injection. Furthermore, hUCMSCs protected the ultrastructure of cardiomyocytes by attenuating mitochondrial swelling and maintaining sarcolemma integrity. CONCLUSIONS: Intramuscular injection of UCMSCs can improve DCM-induced cardiac function impairment and protect the myocardium. These effects may be mediated by regulation of relevant cytokines in serum and the myocardium. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-017-0472-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5273808
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52738082017-02-01 Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats Mao, Chenggang Hou, Xu Wang, Benzhen Chi, Jingwei Jiang, Yanjie Zhang, Caining Li, Zipu Stem Cell Res Ther Research BACKGROUND: Stem cells provide a promising candidate for the treatment of the fatal pediatric dilated cardiomyopathy (DCM). This study aimed to investigate the effects of intramuscular injection of human umbilical cord-derived mesenchymal stem cells (hUCMSCs) on the cardiac function of a DCM rat model. METHODS: A DCM model was established by intraperitoneal injections of doxorubicin in Sprague-Dawley rats. hUCMSCs at different concentrations or cultured medium were injected via limb skeletal muscles, with blank medium injected as the control. The rats were monitored for 4 weeks, meanwhile BNP, cTNI, VEGF, HGF, GM-CSF, and LIF in the peripheral blood were examined by ELISA, and cardiac function was monitored by echocardiography (Echo-CG). Finally, the expression of IGF-1, HGF, and VEGF in the myocardium was examined by histoimmunochemistry and real-time PCR, and the ultrastructure of the myocardium was examined by electron microscopy. RESULTS: Injection of hUCMSCs markedly improved cardiac function in the DCM rats by significantly elevating left ventricular ejection fraction (LVEF) and left ventricular fraction shortening (LVFS). The BNP and cTNI levels in the peripheral blood were reduced by hUCMSCs, while HGF, LIF, GM-CSF, and VEGF were increased by hUCMSCs. Expression of IGF-1, HGF, and VEGF in the myocardium from the DCM rats was significantly increased by hUCMSC injection. Furthermore, hUCMSCs protected the ultrastructure of cardiomyocytes by attenuating mitochondrial swelling and maintaining sarcolemma integrity. CONCLUSIONS: Intramuscular injection of UCMSCs can improve DCM-induced cardiac function impairment and protect the myocardium. These effects may be mediated by regulation of relevant cytokines in serum and the myocardium. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-017-0472-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-28 /pmc/articles/PMC5273808/ /pubmed/28129792 http://dx.doi.org/10.1186/s13287-017-0472-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mao, Chenggang
Hou, Xu
Wang, Benzhen
Chi, Jingwei
Jiang, Yanjie
Zhang, Caining
Li, Zipu
Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title_full Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title_fullStr Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title_full_unstemmed Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title_short Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
title_sort intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273808/
https://www.ncbi.nlm.nih.gov/pubmed/28129792
http://dx.doi.org/10.1186/s13287-017-0472-y
work_keys_str_mv AT maochenggang intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT houxu intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT wangbenzhen intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT chijingwei intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT jiangyanjie intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT zhangcaining intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats
AT lizipu intramuscularinjectionofhumanumbilicalcordderivedmesenchymalstemcellsimprovescardiacfunctionindilatedcardiomyopathyrats